3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase 1/2
3
Phase 1
3
Phase NA
1
Phase EARLY_PHASE1
1
Phase 4
1
Phase 3
1
Status
Completed
16
Recruiting
12
Active not recruiting
8
Terminated
4
Unknown
2
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
34
Genitourinary
29
Breast
25
Thoracic
23
Lymphoid
22
Other hematologic neoplasm
15
Gynecologic
14
Head & Neck
10
CNS
8
Sarcoma
5
Dermatologic
5
Tumor-Agnostic
4
Plasma cell
4
Myeloid
3
Endocrine
3
Classical hematology
3
Other solid neoplasm
1
Other neoplasm
1
Other
1
NET
1
Conditions
Neuroendocrine Tumors
1
Interventions
lutetium Lu 177 dotatate
1
Introns
1
177Lu-octreotate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Withdrawn
×
NET
×
Clear all
NCT01860742
2016-04-05
CASTOR
Jules Bordet Institute
Phase 3
Withdrawn